Micro Cap Stock News Hubb
Advertisement Banner
  • Home
  • News
  • Stocks & Capital News
  • Contact
No Result
View All Result
  • Home
  • News
  • Stocks & Capital News
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Stocks & Capital News

Snap, Apple, Boeing and more

admin by admin
March 6, 2023
in Stocks & Capital News


Check out the companies making headlines in midday trading.

An Apple store on Nanjing Road Pedestrian Street in Shanghai, China, on December 16, 2022.

CFOTO | Future Publishing | Getty Images

Snap — The tech company’s shares gained almost 13%, having their strongest day since November. Shares gained as U.S. lawmakers prepare legislation that would give President Joe Biden the authority to ban TikTok, one of Snapchat’s primary competitors.

Apple — Shares advanced more than 3% after Goldman Sachs initiated coverage of the big technology stock as a buy. The firm said Apple could get boosted by its services business.

Credit Suisse — Shares were down about 1% after former top shareholder Harris Associates sold its entire stake in Credit Suisse, according to a Financial Times report. Harris Associates CIO David Herro said there are questions about the future of the franchise and large outflows from its wealth management division.

Boeing — The aerospace company’s shares fell 1.6% following reports that software issues could delay deliveries of its MAX and 787 aircraft by up to a year.

RH — The furniture store, formerly known as Restoration Hardware, saw its stock dip more than 2% after Jefferies downgraded it to hold from buy. The Wall Street firm said the luxury housing market is struggling to stabilize, which will impact RH’s business.

Biomarin Pharmaceutical — Shares dropped by more than 6% after competitor BridgeBio Pharma reported positive trial data on its candidate for achondroplasia, the most common form of dwarfism, in children, which could challenge Biomarin’s Voxzogo medication. 

Emerson Electric — Shares rose about 3% following an upgrade by UBS to buy from neutral. The Wall Street firm said the derating of Emerson Electric is overdone.

Vir Biotechnology — The biotech stock added 1.4% following a JPMorgan upgrade to overweight from neutral. The firm said the company has a strong drug pipeline, specifically mentioning its trials for hepatitis B and the flu.

Domino’s Pizza — Domino’s Pizza shares advanced more than 4%. On Friday, Gordon Haskett downgraded the stock to hold from buy, and lowered its price target, saying the pizza chain will find it difficult to “easily drive a return to 6-10% average annual system sales growth.”

— CNBC’s Alex Harring, Yun Li, Sarah Min and Michelle Fox contributed reporting.



Source link

Tags: Apple IncBiomarin Pharmaceutical IncBoeing CoBreaking News: MarketsBridgeBio Pharma Incbusinessbusiness newsCredit Suisse Group AGDomino's Pizza IncEconomyEmerson Electric CoJoe BidenMarket InsiderMarketsRHSnap IncStock marketsUnited StatesVir Biotechnology Inc
Previous Post

Beginner-Friendly Trading Techniques for Crypto Forex Currency, Live Signals Included – Analytics & Forecasts – 5 March 2023

Next Post

Bionano Genomics, Inc. (BNGO) Presents at Cowen 43rd Annual Healthcare Conference (Transcript)

Next Post

Bionano Genomics, Inc. (BNGO) Presents at Cowen 43rd Annual Healthcare Conference (Transcript)

Recommended

Psychedelic Sunday: Competitive Strategies (undefined:ATAI)

2 months ago

AW Instruction and description (basic functions) – My Trading – 2 March 2023

4 weeks ago

© Micro Cap Stocks News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Stocks & Capital News
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Stocks & Capital News
  • Contact

© 2022 Micro Cap Stock News Hubb All rights reserved.